A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Merck Sharp & Dohme LLC
Novita Pharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Labcorp Corporation of America Holdings, Inc
Stanford University
DxTerity Diagnostics
Five Prime Therapeutics, Inc.
Celldex Therapeutics
Quadriga Biosciences, Inc.
Ludwig Institute for Cancer Research
Incyte Corporation
Exact Sciences Corporation
Boryung Pharmaceutical Co., Ltd
MacroGenics
Weill Medical College of Cornell University
Shionogi Inc.
Seagen Inc.
Incyte Corporation
Seagen Inc.
Gilead Sciences
Seagen Inc.
Incyte Corporation
Abramson Cancer Center at Penn Medicine
Osaka University
Eli Lilly and Company
Swiss Cancer Institute
University of Kansas Medical Center
Roswell Park Cancer Institute
Amgen
Santa Maria Biotherapeutics
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Celldex Therapeutics
Fox Chase Cancer Center
OHSU Knight Cancer Institute
University of Arizona
Stanford University
City of Hope Medical Center
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
ImmunoFrontier, Inc.
Cellectar Biosciences, Inc.
Dartmouth-Hitchcock Medical Center
INSYS Therapeutics Inc